Global Joint Pain Injection Market- Market Overview:

The global joint pain injection market is expected to grow from USD 4.80 billion in 2022 to USD 8.30 billion by 2030, at a CAGR of 7.10% during the Projection period 2023-2030. The growing prevalence of osteoarthritis mainly drives the growth of the joint pain injection market.

An injury to any of the tendons, bursae, or ligaments surrounding the joint may result in discomfort. Joint pain injections are drugs injected directly into the joints to help the patient feel less inflamed and uncomfortable. Joint pain injections, often referred to as intra-articular injections, are frequently used to treat inflammatory joint illnesses such as psoriatic arthritis, rheumatoid arthritis, bursitis, osteoarthritis, gout, and other types of joint pain. Joint pain, stiffness, redness, and a decline in physical activity are some signs of arthritis. The two most common varieties of arthritis are rheumatoid arthritis, an inflammatory condition that primarily affects the hands and feet, and osteoarthritis, a degenerative joint disease. Age, increasing obesity rates, a lack of physical exercise, and bone mineral density decrease are all risk factors for osteoarthritis. Corticosteroid and hyaluronic acid injections are frequently utilized to reduce swelling and discomfort in affected joint areas. Joint pain injections are given directly into the joints to ease discomfort and reduce swelling and inflammation. The majority of the time, pre-existing illnesses or disorders in the elderly population are the cause of joint discomfort. Arthritis is a widespread condition that primarily affects the spine's knee, ankle, hip, shoulder, elbow, and facet joints. It causes joint pain, which causes inflammation and adds to joint discomfort. Additionally, during the joint pain injections market Projection, there is predicted to be a rise in the prevalence of osteoarthritis and rheumatoid arthritis and a corresponding rise in the demand for cheap therapies for these disorders.

Sample Request: - Global Joint Pain Injection Market

Market Dynamics:

Drivers:                          

• Growing prevalence of Obesity and Osteoarthritis

The rising geriatric population and sedentary lifestyle in industrialized and developing nations are just two factors contributing to the increased frequency of musculoskeletal illnesses like osteoarthritis. For instance, the World Health Organization (WHO) projects that in 2020, 1.71 billion individuals will be affected by musculoskeletal illnesses globally. Additionally, according to Healio estimates, 303.1 million people worldwide had osteoarthritis in 2018. As a result, there is a sizable patient population with osteoarthritis and increased awareness of the importance of early detection and treatment, driving demand for pain relief products like injections for joint pain. Rising healthcare per capita costs in industrialized nations and new product releases by market participants also increase the demand for intra-articular injections.

Restraints:

• High cost of injections

The rising incidence of musculoskeletal disorders and the spike in demand for efficient treatment drives joint pain injection demand. Additionally, it is believed that the expensive cost of joint injections and strict product approval rules will limit market expansion. For instance, the U.S. FDA denied the approval of tanezumab for the treatment of osteoarthritis pain in March 2021 because to some risk-benefit concerns. Although clinical data indicated that tanezumab could help patients with OA pain, the FDA's Arthritis Advisory Committee (AAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM) decided that, even with the proposed modification efforts, the associated risk for joint destruction, rapidly progressing osteoarthritis, and other safety outcomes were more significant.

Opportunities:

• Growing Preference for Plasma Matrix Therapy and Single Injection Therapy

The aging population and the prevalence of arthritis increase the need for efficient joint pain treatment solutions. The development of cutting-edge treatment options, including platelet-rich plasma injections and plasma matrix therapy, is being done by major participants in the joint pain injections market. The adoption of innovative products is aided by continuing research projects emphasizing novel treatments' advantages. For instance, according to the National Library of Medicine, the anti-inflammatory effect of platelet-rich plasma therapy for joint pain linked with osteoarthritis dramatically decreased discomfort.

Challenges:

• Lack of awareness

Intra-articular injections are less frequently used in underdeveloped nations to alleviate joint pain because of a lack of knowledge about these items. Furthermore, the market's expansion is being constrained by the absence of reimbursement policies for intra-articular injections in these nations.

Segmentation Analysis:

The global joint pain injection market has been segmented based on injection type, end-user, and region.

By Injection Type

The injection type segment is an hyaluronic acid injections, corticosteroid injections, platelets rich plasma injections, and others. The hylauric acid injections segment led the largest share of the joint pain injection market with a market share of around 35.6% in 2022. Patients with osteoarthritis (OA)-related knee discomfort who have already tried ineffective treatments like acetaminophen and other opioids can benefit from hyaluronic acid injections. As a non-surgical treatment option, hyaluronic acid injections have grown in favour, especially given how reluctant clinicians are to regularly administer intraarticular corticosteroid injections. The market participants are putting a lot of effort into creating new products with plenty of benefits and often releasing new products. For instance, through TCM Biotech International Corp. in August 2021, Seikagaku Corporation introduced HyLink, an intra-articular single-injection Visco supplement for the treatment of knee osteoarthritis, in Taiwan. Using cross-linking technology, a hyaluronate hydrogel serves as the major component. Over the Projection period, it is anticipated that the launches will accelerate segment growth.

By Joint Type

The joint type segment is shoulder & elbow, knee & ankle and others. The knee & ankle segment led the largest share of the joint pain injection market with a market share of around 41% in 2022. With the increasing prevalence of knee osteoarthritis, the demand for intra-articular injections for managing knee pain is expected to increase in the near future. As a result of the strin product portfolio offered by key players for the treatment of knee osteoarthritis pain as well as the growing number of patients undergoing treatment, the market is expected to grow.

By End-User

The end-user segment is retail pharmacies, online pharmacies, hospitals pharmacies, and others. The online pharmacies segment led the largest share of the joint pain injection market with a market share of around 46% in 2022. The expansion of the segment is being driven by the increased internet penetration in emerging nations. Additionally, the trend of digitalization has greatly aided the expansion of the online pharmacy market.

Global Joint Pain Injection Market - Sales Analysis.

The sale of the joint pain injection market expanded at a CAGR of 6.3% from 2016 to 2022.

Rising rates of joint pain in developed and developing countries, as well as the quick development of injections that let doctors identify the primary sources of pain and help reduce it quickly, are expected to have an impact on the market's expansion. The muscles, ligaments, and articular capsules are numbed by the anaesthetic medication that is part of the facet joint injections. One of the main factors boosting the output of facet joint injections during the anticipated timeframe has been recognised as rising demand for non-surgical therapy. Additionally, it is anticipated to contribute to the overall facet joint injection build-up during the Projection period, boosting the focus on efficient pain management.

According to the Arthritis Foundation, arthritis is the leading cause of adult disability in the United States. In the US, 300,000 babies and toddlers and 54 million adults have arthritis or another rheumatic condition. In the US, 78 million people would have been given an arthritis diagnosis by 2040. Additionally, approximately 31 million Americans suffer from osteoarthritis, the most prevalent form of arthritis. The market for joint pain injections is anticipated to grow due to the rising prevalence of arthritis and the increased need for disease-modifying therapies. Obesity is associated with a number of joint issues, especially those that impact the knee, such as osteoarthritis and knee pain.

Thus, owing to the aforementioned factors, the global joint pain injection market is expected to grow at a CAGR of 7.10% during the Projection period from 2023 to 2030.

By Regional Analysis:

The regions analyzed for the joint pain injection market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America region dominated the joint pain injection market and held a 38.9% share of the market revenue in 2022.

• The North America region witnessed a major share. Due to the high prevalence of musculoskeletal problems, expanding elderly population, strong industry player presence in the region, improved healthcare infrastructure, public knowledge of accessible technologies, and the concentration of key market participants in the area. The Centers for Disease Control and Prevention (CDC) estimate that millions of Americans experience arthritis-related chronic pain each year. 15 million adults with arthritis, or around one in four, report having very painful joints as a result of their disease. The market in this area is expanding as a result of the increasing rate of adoption of cutting-edge technology. Major market companies are also investing a lot of money in research projects, which would eventually expand the market in North America.
• Asia-Pacific is anticipated to experience significant growth during the Projection period. Due to rising healthcare spending, greater public awareness of non-invasive orthopaedic procedures, continued advancements in implant technology, and high-tech healthcare facilities, the Asia-Pacific joint pain injections market is expected to rise.

Global Joint Pain Injection Market - Country Analysis:

• Germany

Germany's joint pain injection market size was valued at USD 0.10 billion in 2022 and is expected to reach USD 0.18 billion by 2030, at a CAGR of 8% from 2023 to 2030. Due to its huge patient population, Germany held the top spot in the regional market for joint pain in 2021. The increased demand for osteoarthritis therapies will lead to a large increase in the use of hyaluronic acid in Germany.

• China

China’s joint pain injection market size was valued at USD 0.37 billion in 2022 and is expected to reach USD 0.69 billion by 2030, at a CAGR of 8.2% from 2023 to 2030. Due to the widespread musculoskeletal conditions that lead to joint discomfort. Growing public awareness of non-invasive orthopaedic therapies, ongoing implant technology advancements, and cutting-edge medical facilities.

• India

India's joint pain injection market size was valued at USD 0.28 billion in 2022 and is expected to reach USD 0.52 billion by 2030, at a CAGR of 8.1% from 2023 to 2030. Due to India's enormous patient base, growing treatment uptake, rise in the geriatric population, and increased awareness of joint-related illnesses.

Key Industry Players Analysis:

To increase their market position in the global joint pain injection market business, top companies focus on tactics such as adopting new technology, mergers & acquisitions, product developments, collaborations, partnerships, joint ventures, etc.   

• Anika Therapeutics Inc.
• Ferring Pharmaceuticals Inc.
• Bioventus
• Zimmer Biomet Holdings Inc.
• Sanofi
• Allergen Plc.
• Pfizer Inc.
• Chugai Pharmaceutical Co. Ltd
• SEIKAGAKU Corporation
• Ferring B.V.

Latest Development:

• In March 2022, A USD 120,000 donation was made to the Arthritis Foundation by Green Roads, a division of the Valens Company, in support of the organization's effort to improve the quality of life for people who experience chronic pain. Green Roads became the official sustaining sponsor of the Arthritis Foundation as a result of this donation.
• In January 2022, SKYRIZI (risankizumab-rzaa), which can be given as a single injection four times a year, was approved by the US Food and Drug Administration (FDA) for the treatment of people with active psoriatic arthritis (PsA).

Report Metrics

Report Attribute	Details
Study Period	2022-2030
Base year	2022
CAGR (%)	7.10%
Market Size	4.80 billion in 2022
Projection period	2023-2030
Projection unit	Value (USD)
Segments covered	By Injection Type, By Joint Type, By End-User, and By Region.
Report Scope	Revenue Projection, competitive landscape, company ranking, growth factors, and trends
Companies covered	Anika Therapeutics Inc., Ferring Pharmaceuticals Inc., Bioventus, Zimmer Biomet Holdings Inc., Sanofi, Allergen Plc., Pfizer Inc., Chugai Pharmaceutical Co. Ltd, SEIKAGAKU Corporation, and Ferring B.V.
By Injection Type	Hyaluronic Acid Injections Corticosteroid Injections Platelets Rich Plasma Injections Others
By Joint Type	Shoulder & Elbow Knee & Ankle Others
By End-User	Retail Pharmacies Online Pharmacies Hospitals Pharmacies Others
Regional scope	North America Europe Asia-Pacific South America Middle East and Africa

Scope of the Report

Global Joint Pain Injection Market By Injection Type:

• Hyaluronic Acid Injections
• Corticosteroid Injections
• Platelets Rich Plasma Injections
• Others

Global Joint Pain Injection Market By Joint Type:

• Shoulder & Elbow
• Knee & Ankle
• Others

Global Joint Pain Injection Market By End-User:

• Retail Pharmacies
• Online Pharmacies
• Hospitals Pharmacies
• Others

Global Joint Pain Injection Market By Region:

• North America
  • USA
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
• Asia-Pacific
  • Japan
  • China
  • India
  • Korea
  • Southeast Asia
• South America
  • Brazil
  • Peru
• Middle East and Africa
  • UAE
  • South Africa
  • Saudi Arabia

Political Factors- the level of political stability the country has recently experienced. the integrity of the politicians and their susceptibility for corrupt behaviour, as the consequences might lead to high-ranking government officials resigning or being impeached. The laws that the country upholds, especially those that are concerned with trade, like contract law, because they define what is and is not allowed to do For instance, some countries prohibit alcohol or have strict regulations that must be followed, while other governments have bloated bureaucracies that discourage business.

Economic Factors- Whether the market is now organised as a monopoly, oligopoly, or anything more akin to a system of perfect competition. Depending on the country's GDP growth rate, will likely expand in the near future at a varying pace. The amount that people are willing to invest and borrow is influenced by the country's interest rates. Higher rates would encourage more investment, which would boost GDP. How well the financial markets function also affects how well one may raise cash at a fair price, taking demand and supply into account. The country's exchange rate would have an effect on profitability, particularly if it engaged in international trade.

Social Factors- Whether or whether a certain product may be sold to a particular demographic depends significantly on the age and gender distribution of the population. Because makeup is marketed mostly to women, selecting a demographic that is predominately male would result in fewer people being reached than targeting a group that is predominately female. It would be hard to promote a premium product to the broader public if the majority of individuals belonged to a lower class; instead, they would have to concentrate on extremely specialised niche markets. Therefore, the distribution of classes throughout the population is vital. Due to the disparity in educational backgrounds between marketers and the target market, it may be difficult to effectively relate to and attract the target market.

Technological Factors- opponents' aforementioned technological discoveries and advancements. The degree of adoption of a new technology, as well as how quickly it is developing and displacing sales from competitors in the business in question, must all be closely monitored. This would be the level of urgency required to effectively react to the creation, either by matching the technology or developing a unique replacement. The profitability that results could be greatly increased or decreased depending on how technology affects the costs that the majority of enterprises in the sector must bear.

Environmental Factors- The ability to move materials and the finished product may be significantly impacted by the weather at this time. In the event of, say, an unexpected monsoon, this would then affect when the finished product would be delivered. Climate change would cause some goods to lose all of their value. In the case of textiles, warm winter gear has a substantially smaller market in countries where the winter has become quite mild as a result of global warming. Laws may require businesses with high rubbish production to govern their environmental practises.

Legal Factors- As was already stated, the goal of intellectual property laws and other data protection legislation is to protect the ideas and patents of companies who solely profit from the information. The system will lose its competitive edge and is very likely to fail if there is a risk of data theft. Anti-discrimination rules passed by the government are meant to protect employees and ensure that everyone is treated fairly and given the same opportunities, regardless of gender, age, handicap, race, religion, or sexual orientation. Health and safety laws were formed as a result of witnessing the horrifying conditions that people had to work in during and immediately after the industrial revolution.

1. Introduction
   • 1. Objectives of the Study
   • 2. Market Definition
   • 3. Research Scope
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
   • 1. Porter’s Five Forces Analysis
   • 2. Value Chain Analysis
   • 3. Top Investment Pockets
     • 3.1. Market Attractiveness Analysis By Injection Type
     • 3.2. Market Attractiveness Analysis By Joint Type
     • 3.3. Market Attractiveness Analysis By End-User
     • 3.4. Market Attractiveness Analysis By Region
   • 4. Industry Trends
5. Market Dynamics
   • 1. Market Evaluation
   • 2. Drivers
     • 2.1. Growing prevalence of Obesity and Osteoarthiritis
   • 3. Restraints
     • 3.1. High cost of injections
   • 4. Opportunities
     • 4.1. Growing Preference for Plasma Matrix Therapy and Single Injection Therapy
   • 5. Challenges
     • 5.1. Lack of awareness

6. Global Joint Pain Injection Market Analysis and Projection, By Injection Type
   • 1. Segment Overview
   • 2. Hyaluronic Acid Injections
   • 3. Corticosteroid Injections
   • 4. Platelets Rich Plasma Injections
   • 5. Others
7. Global Joint Pain Injection Market Analysis and Projection, By Joint Type
   • 1. Segment Overview
   • 2. Shoulder & Elbow
   • 3. Knee & Ankle
   • 4. Others
8. Global Joint Pain Injection Market Analysis and Projection, By End-User
   • 1. Segment Overview
   • 2. Retail Pharmacies
   • 3. Online Pharmacies
   • 4. Hospitals Pharmacies
   • 5. Others
9. Global Joint Pain Injection Market Analysis and Projection, By Regional Analysis
   • 1. Segment Overview
   • 2. North America
     • 2.1. U.S.
     • 2.2. Canada
     • 2.3. Mexico
   • 3. Europe
     • 3.1. Germany
     • 3.2. France
     • 3.3. U.K.
     • 3.4. Italy
     • 3.5. Spain
   • 4. Asia-Pacific
     • 4.1. Japan
     • 4.2. China
     • 4.3. India
   • 5. South America
     • 5.1. Brazil
   • 6. Middle East and Africa
     • 6.1. UAE
     • 6.2. South Africa

10. Global Joint Pain Injection Market-Competitive Landscape
    • Overview
    • Market Share of Key Players in the Joint Pain Injection Market
      • 2.1. Global Company Market Share
      • 2.2. North America Company Market Share
      • 2.3. Europe Company Market Share
      • 2.4. APAC Company Market Share
    • Competitive Situations and Trends
      • 3.1. Technology Launches and Developments
      • 3.2. Partnerships, Collaborations, and Agreements
      • 3.3. Mergers & Acquisitions
      • 3.4. Expansions

11. Company Profiles
    • Anika Therapeutics Inc.
      • 1.1. Business Overview
      • 1.2. Company Snapshot
      • 1.3. Company Market Share Analysis
      • 1.4. Company Technology Portfolio
      • 1.5. Recent Developments
      • 1.6. SWOT Analysis
    • Ferring Pharmaceuticals Inc.
      • 2.1. Business Overview
      • 2.2. Company Snapshot
      • 2.3. Company Market Share Analysis
      • 2.4. Company Technology Portfolio
      • 2.5. Recent Developments
      • 2.6. SWOT Analysis
    • Bioventus
      • 3.1. Business Overview
      • 3.2. Company Snapshot
      • 3.3. Company Market Share Analysis
      • 3.4. Company Technology Portfolio
      • 3.5. Recent Developments
      • 3.6. SWOT Analysis
    • Zimmer Biomet Holdings Inc.
      • 4.1. Business Overview
      • 4.2. Company Snapshot
      • 4.3. Company Market Share Analysis
      • 4.4. Company Technology Portfolio
      • 4.5. Recent Developments
      • 4.6. SWOT Analysis
    • Sanofi
      • 5.1. Business Overview
      • 5.2. Company Snapshot
      • 5.3. Company Market Share Analysis
      • 5.4. Company Technology Portfolio
      • 5.5. Recent Developments
      • 5.6. SWOT Analysis
    • Allergen Plc.
      • 6.1. Business Overview
      • 6.2. Company Snapshot
      • 6.3. Company Market Share Analysis
      • 6.4. Company Technology Portfolio
      • 6.5. Recent Developments
      • 6.6. SWOT Analysis
    • Pfizer Inc.
      • 7.1. Business Overview
      • 7.2. Company Snapshot
      • 7.3. Company Market Share Analysis
      • 7.4. Company Technology Portfolio
      • 7.5. Recent Developments
      • 7.6. SWOT Analysis
    • Chugai Pharmaceutical Co. Ltd
      • 8.1. Business Overview
      • 8.2. Company Snapshot
      • 8.3. Company Market Share Analysis
      • 8.4. Company Technology Portfolio
      • 8.5. Recent Developments
      • 8.6. SWOT Analysis
    • SEIKAGAKU Corporation
      • 9.1. Business Overview
      • 9.2. Company Snapshot
      • 9.3. Company Market Share Analysis
      • 9.4. Company Technology Portfolio
      • 9.5. Recent Developments
      • 9.6. SWOT Analysis
    • Ferring B.V.
      • Business Overview
      • Company Snapshot
      • Company Market Share Analysis
      • Company Technology Portfolio
      • Recent Developments
      • SWOT Analysis

List of Table

1. Global Joint Pain Injection Market, By Injection Type, 2023–2030 (USD Billion)
2. Global Hyaluronic Acid Injections, Joint Pain Injection Market, By Region, 2023–2030 (USD Billion)
3. Global Corticosteroid Injections, Joint Pain Injection Market, By Region, 2023–2030 (USD Billion)
4. Global Platelets Rich Plasma Injections, Joint Pain Injection Market, By Region, 2023–2030 (USD Billion)
5. Global Others, Joint Pain Injection Market, By Region, 2023–2030 (USD Billion)
6. Global Joint Pain Injection Market, By Joint Type, 2023–2030 (USD Billion)
7. Global Shoulder & Elbow, Joint Pain Injection Market, By Region, 2023–2030 (USD Billion)
8. Global Knee & Ankle, Joint Pain Injection Market, By Region, 2023–2030 (USD Billion)
9. Global Others, Joint Pain Injection Market, By Region, 2023–2030 (USD Billion)
10. Global Joint Pain Injection Market, By End-User 2023–2030 (USD Billion)
11. Global Retail Pharmacies, Joint Pain Injection Market, By Region, 2023–2030 (USD Billion)
12. Global Online Pharmacies, Joint Pain Injection Market, By Region, 2023–2030 (USD Billion)
13. Global Hospitals Pharmacies, Joint Pain Injection Market, By Region, 2023–2030 (USD Billion)
14. Global Others, Joint Pain Injection Market, By Region, 2023–2030 (USD Billion)
15. Global Joint Pain Injection Market, By Region, 2023–2030 (USD Billion)
16. North America Joint Pain Injection Market, By Injection Type, 2023–2030 (USD Billion)
17. North America Joint Pain Injection Market, By Joint Type, 2023–2030 (USD Billion)
18. North America Joint Pain Injection Market, By End-User 2023–2030 (USD Billion)
19. USA Joint Pain Injection Market, By Injection Type, 2023–2030 (USD Billion)
20. USA Joint Pain Injection Market, By Joint Type, 2023–2030 (USD Billion)
21. USA Joint Pain Injection Market, By End-User 2023–2030 (USD Billion)
22. Canada Joint Pain Injection Market, By Injection Type, 2023–2030 (USD Billion)
23. Canada Joint Pain Injection Market, By Joint Type, 2023–2030 (USD Billion)
24. Canada Joint Pain Injection Market, By End-User 2023–2030 (USD Billion)
25. Mexico Joint Pain Injection Market, By Injection Type, 2023–2030 (USD Billion)
26. Mexico Joint Pain Injection Market, By Joint Type, 2023–2030 (USD Billion)
27. Mexico Joint Pain Injection Market, By End-User 2023–2030 (USD Billion)
28. Europe Joint Pain Injection Market, By Injection Type, 2023–2030 (USD Billion)
29. Europe Joint Pain Injection Market, By Joint Type, 2023–2030 (USD Billion)
30. Europe Joint Pain Injection Market, By End-User 2023–2030 (USD Billion)
31. Germany Joint Pain Injection Market, By Injection Type, 2023–2030 (USD Billion)
32. Germany Joint Pain Injection Market, By Joint Type, 2023–2030 (USD Billion)
33. Germany Joint Pain Injection Market, By End-User 2023–2030 (USD Billion)
34. France Joint Pain Injection Market, By Injection Type, 2023–2030 (USD Billion)
35. France Joint Pain Injection Market, By Joint Type, 2023–2030 (USD Billion)
36. France Joint Pain Injection Market, By End-User 2023–2030 (USD Billion)
37. UK Joint Pain Injection Market, By Injection Type, 2023–2030 (USD Billion)
38. UK Joint Pain Injection Market, By Joint Type, 2023–2030 (USD Billion)
39. UK Joint Pain Injection Market, By End-User 2023–2030 (USD Billion)
40. Italy Joint Pain Injection Market, By Injection Type, 2023–2030 (USD Billion)
41. Italy Joint Pain Injection Market, By Joint Type, 2023–2030 (USD Billion)
42. Italy Joint Pain Injection Market, By End-User 2023–2030 (USD Billion)
43. Spain Joint Pain Injection Market, By Injection Type, 2023–2030 (USD Billion)
44. Spain Joint Pain Injection Market, By Joint Type, 2023–2030 (USD Billion)
45. Spain Joint Pain Injection Market, By End-User 2023–2030 (USD Billion)
46. Asia Pacific Joint Pain Injection Market, By Injection Type, 2023–2030 (USD Billion)
47. Asia Pacific Joint Pain Injection Market, By Joint Type, 2023–2030 (USD Billion)
48. Asia Pacific Joint Pain Injection Market, By End-User 2023–2030 (USD Billion)
49. Japan Joint Pain Injection Market, By Injection Type, 2023–2030 (USD Billion)
50. Japan Joint Pain Injection Market, By Joint Type, 2023–2030 (USD Billion)
51. Japan Joint Pain Injection Market, By End-User 2023–2030 (USD Billion)
52. China Joint Pain Injection Market, By Injection Type, 2023–2030 (USD Billion)
53. China Joint Pain Injection Market, By Joint Type, 2023–2030 (USD Billion)
54. China Joint Pain Injection Market, By End-User 2023–2030 (USD Billion)
55. India Joint Pain Injection Market, By Injection Type, 2023–2030 (USD Billion)
56. India Joint Pain Injection Market, By Joint Type, 2023–2030 (USD Billion)
57. India Joint Pain Injection Market, By End-User 2023–2030 (USD Billion)
58. South America Joint Pain Injection Market, By Injection Type, 2023–2030 (USD Billion)
59. South America Joint Pain Injection Market, By Joint Type, 2023–2030 (USD Billion)
60. South America Joint Pain Injection Market, By End-User 2023–2030 (USD Billion)
61. Brazil Joint Pain Injection Market, By Injection Type, 2023–2030 (USD Billion)
62. Brazil Joint Pain Injection Market, By Joint Type, 2023–2030 (USD Billion)
63. Brazil Joint Pain Injection Market, By End-User 2023–2030 (USD Billion)
64. Middle East and Africa Joint Pain Injection Market, By Injection Type, 2023–2030 (USD Billion)
65. Middle East and Africa Joint Pain Injection Market, By Joint Type, 2023–2030 (USD Billion)
66. Middle East and Africa Joint Pain Injection Market, By End-User 2023–2030 (USD Billion)
67. UAE Joint Pain Injection Market, By Injection Type, 2023–2030 (USD Billion)
68. UAE Joint Pain Injection Market, By Joint Type, 2023–2030 (USD Billion)
69. UAE Joint Pain Injection Market, By End-User 2023–2030 (USD Billion)
70. South Africa Joint Pain Injection Market, By Injection Type, 2023–2030 (USD Billion)
71. South Africa Joint Pain Injection Market, By Joint Type, 2023–2030 (USD Billion)
72. South Africa Joint Pain Injection Market, By End-User 2023–2030 (USD Billion)

List of Figures 

1. Global Joint Pain Injection Market Segmentation
2. Joint Pain Injection Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Joint Pain Injection Market Attractiveness Analysis By Injection Type
9. Global Joint Pain Injection Market Attractiveness Analysis By Joint Type
10. Global Joint Pain Injection Market Attractiveness Analysis By End-User
11. Global Joint Pain Injection Market Attractiveness Analysis By Region
12. Global Joint Pain Injection Market: Dynamics
13. Global Joint Pain Injection Market Share By Injection Type (2023 & 2030)
14. Global Joint Pain Injection Market Share By Joint Type (2023 & 2030)
15. Global Joint Pain Injection Market Share By End-User (2023 & 2030)
16. Global Joint Pain Injection Market Share by Regions (2023 & 2030)
17. Global Joint Pain Injection Market Share by Company (2021)